Method for the manufacture of solid dosage forms
AssigneeAron H. Blaesi
InventorsAron H. Blaesi, Nannaji Saka
Life of this patent
Estimating the term…
Abstract
In this specification, a method for the manufacture of solid dosage forms is disclosed. The method includes extruding a plasticized matrix through an exit port of an extrusion channel to form one or more plasticized fibers, structuring said fibers to a three dimensional structural network by patterning on a translating or rotating stage, and solidifying the patterned structure.
Claims26
A method of manufacturing pharmaceutical solid dosage forms comprising the steps of:
- injecting at least one excipient and at least one solvent into an extrusion channel having a cross section extending along its length inside a housing;
- mixing the at least one excipient and the at least one solvent to form a plasticized matrix;
- conveying the plasticized matrix towards an exit port of the extrusion channel by applying mechanical work on the plasticized matrix;
- extruding the plasticized matrix through an exit port to form one or more plasticized fibers;
- structuring one or more plasticized fibers to a three dimensional structural network by depositing said fibers along a path defined by motion of a translating or rotating stage;
- and solidifying the deposited three dimensional structural network of one or more fibers by application of a gas flow through said network;
- wherein the three dimensional structural network of one or more fibers is used in the pharmaceutical solid dosage form.
A method of manufacturing pharmaceutical solid dosage forms comprising the steps of:
- injecting one or more excipients into an extrusion channel having a cross section extending along its length inside a housing, wherein at least one excipient melts upon heating;
- heating the injected one or more excipients to form a plasticized matrix;
- conveying the plasticized matrix towards an exit port of the extrusion channel by applying mechanical work on the plasticized matrix;
- extruding the plasticized matrix through an exit port to form one or more plasticized fibers;
- structuring one or more plasticized fibers to a three dimensional structural network by depositing said fibers along a path defined by motion of a translating or rotating stage;
- and solidifying the deposited three dimensional structural network of one or more fibers by application of a gas flow through said network;
- wherein the three dimensional structural network of one or more fibers is used in the pharmaceutical solid dosage form.
A method of manufacturing pharmaceutical solid dosage forms comprising the steps of:
- injecting at least a plasticized matrix into an extrusion channel having a cross section extending along its length inside a housing;
- conveying the plasticized matrix towards an exit port of the extrusion channel by applying mechanical work on the plasticized matrix;
- extruding the plasticized matrix through an exit port to form one or more plasticized fibers;
- structuring one or more plasticized fibers to a three dimensional structural network by depositing said fibers along a path defined by motion of a translating or rotating stage;
- and solidifying the deposited three dimensional structural network of one or more fibers by application of a gas flow through said network;
- wherein the three dimensional structural network of one or more fibers is used in the pharmaceutical solid dosage form.
A pharmaceutical solid dosage form comprising:
- a three dimensional fiber network structure comprising one or more fibers with average fiber thickness in the range of 1.75 μm to 2.5 mm;
- said fibers having at least one excipient through the fiber thickness;
- said fibers further comprising fiber segments separated and spaced from adjoining fiber segments by free spacings;
- wherein the dosage form is manufactured by a method comprising the steps of:
- injecting one or more excipients into an extrusion channel having a cross section extending along its length inside a housing, wherein at least one excipient melts upon heating;
- heating the injected one or more active ingredients and one or more excipients to form a plasticized matrix;
- conveying the plasticized matrix towards an exit port of the extrusion channel by applying mechanical work on the plasticized matrix;
- extruding the plasticized matrix through an exit port to form one or more plasticized fibers;
- structuring one or more plasticized fibers to a three dimensional structural network by depositing said fibers along a path defined by motion of a translating or rotating stage;
- and
- solidifying the deposited three dimensional structural network of one or more fibers by application of a gas flow through said network.
A pharmaceutical solid dosage form comprising:
- a three dimensional fiber network structure comprising one or more fibers with average fiber thickness in the range of 1.75 μm to 2.5 mm;
- said fibers having at least one excipient through the fiber thickness;
- said fibers further comprising fiber segments separated and spaced from adjoining fiber segments by free spacings;
- wherein the dosage form is manufactured by a method comprising the steps of:
- injecting at least one least one excipient and at least one solvent into an extrusion channel having a cross section extending along its length inside a housing;
- mixing the at least one excipient and the at least one solvent to form a plasticized matrix;
- conveying the plasticized matrix towards an exit port of the extrusion channel by applying mechanical work on the plasticized matrix;
- extruding the plasticized matrix through an exit port to form one or more plasticized fibers;
- structuring one or more plasticized fibers to a three dimensional structural network by depositing said fibers along a path defined by motion of a translating or rotating stage;
- and
- solidifying the deposited three dimensional structural network of one or more fibers by application of a gas flow through said network.
Dependencies are inferred from the claim text.